Together Pharma Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Nissim Bracha

Chief executive officer

₪420.0k

Total compensation

CEO salary percentagen/a
CEO tenure6.6yrs
CEO ownership22.3%
Management average tenureno data
Board average tenure6.6yrs

Recent management updates

Recent updates

Market Cool On Together Pharma Ltd's (TLV:TGTR) Revenues

Nov 04
Market Cool On Together Pharma Ltd's (TLV:TGTR) Revenues

Is Together Pharma (TLV:TGTR) A Risky Investment?

Sep 13
Is Together Pharma (TLV:TGTR) A Risky Investment?

Investors Holding Back On Together Pharma Ltd (TLV:TGTR)

Aug 02
Investors Holding Back On Together Pharma Ltd (TLV:TGTR)

Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital

May 31
Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital

Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce

Apr 04
Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce

A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price

Dec 28
A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price

Returns At Together Pharma (TLV:TGTR) Are On The Way Up

Nov 13
Returns At Together Pharma (TLV:TGTR) Are On The Way Up

Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet

Oct 09
Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Sep 03
Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Sep 03
Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Is Together Pharma (TLV:TGTR) Using Debt Sensibly?

May 27
Is Together Pharma (TLV:TGTR) Using Debt Sensibly?

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Jan 05
Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital

Oct 28
Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Sep 03
Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger

Jul 29
Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger

Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden

Apr 08
Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden

Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?

Dec 24
Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?

CEO

Nissim Bracha (57 yo)

6.6yrs

Tenure

₪420,000

Compensation

Mr. Nissim Bracha has been Chief Executive Officer at Together Pharma Ltd. and serves as its Director since May 2, 2018 and also served as its Partner.


Board Members

NamePositionTenureCompensationOwnership
Nissim Bracha
CEO & Director6.6yrs₪420.00k22.27%
₪ 12.3m
Hadar Ron
Independent Director5.7yrsno datano data
Irit Ben Ami
Independent Director8.6yrsno datano data
Oren Ariel
Member of Advisory Boardno datano datano data
Tal Elyashiv
Member of Advisory Boardno datano datano data
Eli Levi
Member of Advisory Boardno datano datano data
Ronen Samucha
Member of Advisory Boardno datano datano data
Isaac Edry
Member of Advisory Boardno datano datano data
Yochanan Danino
Chairman of the Board5.8yrs₪432.00k0.29%
₪ 160.5k
Nir Sosinsky
Director6.6yrs₪420.00k16.63%
₪ 9.2m
Guy Attia
Director6.6yrs₪420.00k22.7%
₪ 12.6m
Haim Yosefi
Independent Director4.2yrsno datano data

6.6yrs

Average Tenure

63yo

Average Age

Experienced Board: TGTR's board of directors are considered experienced (6.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 09:39
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Together Pharma Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution